Answers are grounded in this paper and cite their sources.
Varicocele is a prevalent urological condition shown to affect about 15% of the male population. Notably, up to 40% of those affected face a high chance of infertility. Percutaneous embolization has become a less invasive option to surgical ligation that works just as well and causes less harm. Post-embolization syndrome (PES), which includes pain and inflammation after a procedure, remains poorly understood because reports from different studies are highly variable and there are no agreed-upon diagnostic criteria. A systematic review and meta-analysis was conducted in accordance with PRISMA 2020 guidelines. Studies that looked at pain or PES-related results after varicocele embolization were considered eligible. Of 753 initially identified records, 11 studies met inclusion criteria. The reported incidence of post‑embolization syndrome varied widely, ranging from 0.4% to 100% across studies, largely reflecting differences in how PES was defined (e.g., any post‑procedural pain versus specific complication criteria). The most common clinical presentations were scrotal, inguinal, or abdominal pain, often self‑limited, with occasional low‑grade fever or malaise. Most cases were managed conservatively (rest, non‑steroidal anti‑inflammatory drugs, or simple analgesics); no study reported routine use of invasive interventions for PES. Symptom duration, where reported, typically ranged from a few days to approximately three weeks. Post‑embolization syndrome following varicocele embolization appears to be a relatively common but generally mild and self‑limited condition. However, its reported incidence varies too widely to allow a precise pooled estimate, primarily due to the absence of standardized diagnostic criteria and heterogeneous reporting across studies.
No takes yet. Share an insight, caveat, or question.
Almarshedi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: